You have 9 free searches left this month | for more free features.

ARQ 751

Showing 1 - 25 of 89

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cancer, Solid Tumors Trial in United States (Vevorisertib, Fulvestrant, Paclitaxel)

Terminated
  • Cancer
  • Solid Tumors
  • Las Vegas, Nevada
  • +5 more
Jun 14, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
  • Birmingham, Alabama
  • +91 more
Jan 26, 2023

Seborrheic Dermatitis Trial in United States (ARQ-154)

Completed
  • Seborrheic Dermatitis
  • Beverly Hills, California
  • +38 more
Nov 30, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle
  • Birmingham, Alabama
  • +75 more
Jan 26, 2023

Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)

Completed
  • Chronic Plaque Psoriasis
  • ARQ-151 0.3% cream
  • ARQ-151 vehicle cream
  • Scottsdale, Arizona
  • +38 more
Dec 5, 2022

Chronic Plaque Psoriasis Trial in Canada, United States (Topical roflumilast)

Enrolling by invitation
  • Chronic Plaque Psoriasis
  • Topical roflumilast
  • Beverly Hills, California
  • +68 more
Nov 9, 2022

Psoriasis Trial in Brisbane, Adelaide, Grafton (BFI-751, EU-STELARA®, US-STELARA®)

Completed
  • Psoriasis
  • Brisbane, Queensland, Australia
  • +2 more
Mar 23, 2022

Plaque Psoriasis Trial in Worldwide (ARQ-154 foam 0.3%, ARQ-154 vehicle foam)

Completed
  • Plaque Psoriasis
  • Roflumilast foam 0.3%
  • Vehicle foam
  • Rogers, Arkansas
  • +46 more
Oct 24, 2022

Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 - Active, ARQ-154 Vehicle)

Completed
  • Seborrheic Dermatitis
  • ARQ-154 - Active
  • ARQ-154 Vehicle
  • Scottsdale, Arizona
  • +52 more
Aug 4, 2022

Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 foam 0.3%, ARQ-154 vehicle foam)

Completed
  • Seborrheic Dermatitis
  • ARQ-154 foam 0.3%
  • ARQ-154 vehicle foam
  • Fremont, California
  • +23 more
Aug 4, 2022

Vitiligo Trial in United States (ARQ-252 cream 0.3%, ARQ-252 Vehicle cream, NB-UVB phototherapy active treatment)

Terminated
  • Vitiligo
  • ARQ-252 cream 0.3%
  • +3 more
  • San Diego, California
  • +4 more
Aug 4, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)

Active, not recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle
  • Montgomery, Alabama
  • +48 more
Aug 10, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle Cream)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle Cream
  • Birmingham, Alabama
  • +52 more
Aug 4, 2022

Scalp Psoriasis Trial in Canada, United States (ARQ-154 Foam 0.3%, ARQ-154 Vehicle)

Completed
  • Scalp Psoriasis
  • ARQ-154 Foam 0.3%
  • ARQ-154 Vehicle
  • Scottsdale, Arizona
  • +48 more
Aug 4, 2022

Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

Recruiting
  • Hematologic Malignancies
  • Torrance, California
  • +51 more
Jan 12, 2023

Psoriasis, Plaque Psoriasis Trial in Canada, Dominican Republic, United States (ARQ-151 cream 0.3%)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • ARQ-151 cream 0.3%
  • Mountain Brook, Alabama
  • +17 more
Aug 2, 2022

Psoriasis, Plaque Psoriasis Trial in Canada, Dominican Republic, United States (ARQ-151 cream 0.3%)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • ARQ-151 cream 0.3%
  • Mountain Brook, Alabama
  • +16 more
Aug 2, 2022

Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)

Completed
  • Chronic Plaque Psoriasis
  • Roflumilast 0.3% cream
  • Vehicle Cream
  • Encinitas, California
  • +39 more
Dec 5, 2022

Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

Terminated
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
May 31, 2022

Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

Completed
  • Plaque Psoriasis
  • Roflumilast Cream 0.3%
  • +2 more
  • Beverly Hills, California
  • +29 more
Aug 31, 2022

Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorders Trial (ARQ 092)

No longer available
  • Proteus Syndrome
  • +2 more
  • ARQ 092
  • (no location specified)
Jul 31, 2021

Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,

Terminated
  • Recurrent Pediatric ALL
  • +3 more
  • Los Angeles, California
  • +4 more
Feb 22, 2021

Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

Completed
  • Sarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021

Colorectal Cancer Metastatic, C-met Overexpression Trial in Rozzano (Tivantinib (ARQ197))

Completed
  • Colorectal Cancer Metastatic
  • C-met Overexpression
  • Tivantinib (ARQ197)
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Obese Trial (high flow nasal oxygen device (HFNO))

Not yet recruiting
  • Obese
  • high flow nasal oxygen device (HFNO)
  • (no location specified)
Jun 2, 2021